Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell.
about
Survivin: a unique target for tumor therapyLocalization and upregulation of survivin in cancer health disparities: a clinical perspectiveAdoptive T Cell Therapy Targeting CD1 and MR1Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlookCreation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergensHuman cell-based artificial antigen-presenting cells for cancer immunotherapy.Specific roles of each TCR hemichain in generating functional chain-centric TCR.Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell ReceptorsArtificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway.A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1+ TCRs.Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs.Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly.
P2860
Q26747332-306A9112-FE98-48C3-BD15-01343BA7181AQ26799719-9753B0FC-F3AC-4FE5-BFD0-7008957BA546Q26998503-22AEAC3A-E03E-442D-9F12-47B8B0837C79Q27004178-C30C7992-2FC6-4C1A-92F5-7757A513EFBFQ28829665-231E691F-B59D-4238-AE71-373BD9643294Q34391263-FCA83AD8-51E8-43FD-BB03-3D54EBEFDD0BQ35205495-D27D52CA-1F3A-474A-966F-7E997681AB6BQ35623772-7D3C6E72-7BD8-4DAB-9442-CECC184386C6Q36026142-E8C57F67-AB31-43B9-9D2A-D960A5D95041Q37109545-5B776DD9-87AA-403B-A049-D43EDF8F67ECQ38217593-E222F974-8D0B-4496-967B-C55DA6690B44Q41503180-B19A70D5-4D66-41F4-8A12-7FA28A6CC8F3Q41988716-E1C8CD20-49D9-4FE6-B681-18A886BE0451Q47296458-B1E2806C-7740-4605-AB94-01E8845A91CAQ48127662-F94961DD-CC8D-4974-BFDA-F8B0A5AA920CQ52349756-E9E5D5F6-8F69-4711-9AD6-70FDEE14F8FF
P2860
Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Induction of HLA-DP4-restricte ...... icial antigen-presenting cell.
@en
Induction of HLA-DP4-restricte ...... icial antigen-presenting cell.
@nl
type
label
Induction of HLA-DP4-restricte ...... icial antigen-presenting cell.
@en
Induction of HLA-DP4-restricte ...... icial antigen-presenting cell.
@nl
prefLabel
Induction of HLA-DP4-restricte ...... icial antigen-presenting cell.
@en
Induction of HLA-DP4-restricte ...... icial antigen-presenting cell.
@nl
P2093
P2860
P1476
Induction of HLA-DP4-restricte ...... icial antigen-presenting cell.
@en
P2093
Alla Berezovskaya
Lee M Nadler
Makito Tanaka
Marcus O Butler
Naoto Hirano
Osamu Imataki
Sascha Ansén
P2860
P304
P356
10.1158/1078-0432.CCR-10-3083
P407
P577
2011-06-24T00:00:00Z